The Role of PKM2 in Diabetic Microangiopathy

References

• Hu M, Fang J, Wang H, Zhou S. Proteome and phosphoproteome analyses reveal the kinase regulatory network involved in glycogen synthesis kinase 3beta. Front Genet. 2021;12:657140.
   Web of Science ®Google Scholar
• Heerspink HJL, Parving HH, Andress DL, et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (sonar): a double-blind, randomised, placebo-controlled trial. Lancet. 2019;393(10184):1937–1947.
   PubMed Web of Science ®Google Scholar
• Burns JS, Manda G. Metabolic pathways of the warburg effect in health and disease: perspectives of choice, chain or chance. Int J Mol Sci. 2017;18(12):2755.
   PubMed Web of Science ®Google Scholar
• Bertelsen LB, Hansen ESS, Sadowski T, Ruf S, Laustsen C. Hyperpolarized pyruvate to measure the influence of pkm2 activation on glucose metabolism in the healthy kidney. NMR Biomed. 2021;34(11):e4583.
   Web of Science ®Google Scholar
• Kong Q, Li N, Cheng H, et al. Hspa12a is a novel player in nonalcoholic steatohepatitis via promoting nuclear pkm2-mediated m1 macrophage polarization. Diabetes. 2019;68(2):361–376.
   PubMed Web of Science ®Google Scholar
• Yang P, Li Z, Li H, Lu Y, Wu H, Li Z. Pyruvate kinase m2 accelerates pro-inflammatory cytokine secretion and cell proliferation induced by lipopolysaccharide in colorectal cancer. Cell Signal. 2015;27(7):1525–1532.
   Web of Science ®Google Scholar
• Luo W, Semenza GL. Emerging roles of pkm2 in cell metabolism and cancer progression. Trends Endocrinol Metab. 2012;23(11):560–566.
   PubMed Web of Science ®Google Scholar
• Israelsen WJ, Vander Heiden MG. Pyruvate kinase: function, regulation and role in cancer. Semin Cell Dev Biol. 2015;43:43–51.
   PubMed Web of Science ®Google Scholar
• Lang N, Wang C, Zhao J, Shi F, Wu T, Cao H. Long noncoding rna bcyrn1 promotes glycolysis and tumor progression by regulating the mir149/pkm2 axis in nonsmallcell lung cancer. Mol Med Rep. 2020;21(3):1509–1516.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Deng X, Liu Y, Liu Y, Sun L, Chen F. Pkm2, function and expression and regulation. Cell Biosci. 2019;9:52.
   PubMed Web of Science ®Google Scholar
• Dong G, Mao Q, Xia W, et al. Pkm2 and cancer: the function of pkm2 beyond glycolysis. Oncol Lett. 2016;11(3):1980–1986.
   PubMed Web of Science ®Google Scholar
• Wang P, Sun C, Zhu T, Xu Y. Structural insight into mechanisms for dynamic regulation of pkm2. Protein Cell. 2015;6(4):275–287.
   Web of Science ®Google Scholar
• Alquraishi M, Puckett DL, Alani DS, et al. Pyruvate kinase m2: a simple molecule with complex functions. Free Radic Biol Med. 2019;143:176–192.
   Web of Science ®Google Scholar
• Zhu S, Guo Y, Zhang X, et al. Pyruvate kinase m2 (pkm2) in cancer and cancer therapeutics. Cancer Lett. 2021;503:240–248.
   PubMed Web of Science ®Google Scholar
• Allen AE, Locasale JW. Glucose metabolism in cancer: the saga of pyruvate kinase continues. Cancer Cell. 2018;33(3):337–339.
   Web of Science ®Google Scholar
• Morgan HP, O’Reilly FJ, Wear MA, et al. M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation. Proc Natl Acad Sci U S A. 2013;110(15):5881–5886.
   Web of Science ®Google Scholar
• Xu J, Jiang C, Wang X, et al. Upregulated pkm2 in macrophages exacerbates experimental arthritis via stat1 signaling. J Immunol. 2020;205(1):181–192.
   PubMed Web of Science ®Google Scholar
• He CL, Bian YY, Xue Y, et al. Pyruvate kinase m2 activates mtorc1 by phosphorylating akt1s1. Sci Rep. 2016;6:21524.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li X, Yang W, et al. Pkm2 regulates chromosome segregation and mitosis progression of tumor cells. Mol Cell. 2014;53(1):75–87.
   PubMed Web of Science ®Google Scholar
• Chiu CF, Weng JR, Lee SL, et al. Osu-a9 induced-reactive oxygen species cause cytotoxicity in duodenal and gastric cancer cells by decreasing phosphorylated nuclear pyruvate kinase m2 protein levels. Biochem Pharmacol. 2020;174:113811.
   Web of Science ®Google Scholar
• Li Q, Leng K, Liu Y, et al. The impact of hyperglycaemia on pkm2-mediated nlrp3 inflammasome/stress granule signalling in macrophages and its correlation with plaque vulnerability: an in vivo and in vitro study. Metabolism. 2020;107:154231.
   Web of Science ®Google Scholar
• Liang J, Cao R, Wang X, et al. Mitochondrial pkm2 regulates oxidative stress-induced apoptosis by stabilizing bcl2. Cell Res. 2017;27(3):329–351.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Terauchi Y. Present status of clinical deployment of glucokinase activators. J Diabetes Investig. 2015;6(2):124–132.
   PubMed Web of Science ®Google Scholar
• Sizemore ST, Zhang M, Cho JH, et al. Pyruvate kinase m2 regulates homologous recombination-mediated DNA double-strand break repair. Cell Res. 2018;28(11):1090–1102.
   Web of Science ®Google Scholar
• Qi W, Li Q, Gordin D, King GL. Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism. J Mol Med (Berl). 2018;96(5):373–381.
   Web of Science ®Google Scholar
• Qi W, Keenan HA, Li Q, et al. Pyruvate kinase m2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat Med. 2017;23(6):753–762.
   Web of Science ®Google Scholar
• Wang S, Yang Z, Gao Y, et al. Pyruvate kinase, muscle isoform 2 promotes proliferation and insulin secretion of pancreatic beta-cells via activating wnt/ctnnb1 signaling. Int J Clin Exp Pathol. 2015;8(11):14441–14448.
   Web of Science ®Google Scholar
• Palsson-McDermott EM, Curtis AM, Goel G, et al. Pyruvate kinase m2 regulates hif-1alpha activity and il-1beta induction and is a critical determinant of the warburg effect in lps-activated macrophages. Cell Metab. 2015;21(2):347.
   Web of Science ®Google Scholar
• Palsson-McDermott EM, Curtis AM, Goel G, et al. Pyruvate kinase m2 regulates hif-1alpha activity and il-1beta induction and is a critical determinant of the warburg effect in lps-activated macrophages. Cell Metab. 2015;21(1):65–80.
   PubMed Web of Science ®Google Scholar
• Nakatsu D, Horiuchi Y, Kano F, et al. L-cysteine reversibly inhibits glucose-induced biphasic insulin secretion and atp production by inactivating pkm2. Proc Natl Acad Sci U S A. 2015;112(10):E1067–1076.
   PubMed Web of Science ®Google Scholar
• Sharma K. Mitochondrial hormesis and diabetic complications. Diabetes. 2015;64(3):663–672.
   PubMed Web of Science ®Google Scholar
• Damasceno LEA, Prado DS, Veras FP, et al. Pkm2 promotes th17 cell differentiation and autoimmune inflammation by fine-tuning stat3 activation. J Exp Med. 2020;217(10):e20190613.
   PubMed Web of Science ®Google Scholar
• Barrett EJ, Liu Z, Khamaisi M, et al. Diabetic microvascular disease: an endocrine society scientific statement. J Clin Endocrinol Metab. 2017;102(12):4343–4410.
   PubMed Web of Science ®Google Scholar
• Esen I, Jiemy WF, van Sleen Y, et al. Plasma pyruvate kinase m2 as a marker of vascular inflammation in giant cell arteritis. Rheumatology. 2021;1:keab814.
   Google Scholar
• Takagaki Y, Shi S, Katoh M, Kitada M, Kanasaki K, Koya D. Dipeptidyl peptidase-4 plays a pathogenic role in bsa-induced kidney injury in diabetic mice. Sci Rep. 2019;9(1):7519.
   PubMed Web of Science ®Google Scholar
• Ouyang X, Han SN, Zhang JY, et al. Digoxin suppresses pyruvate kinase m2-promoted hif-1alpha transactivation in steatohepatitis. Cell Metab. 2018;27(5):1156.
   Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Atak BM, et al. Is neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Invest. 2020;50(3):e13206.
   PubMed Web of Science ®Google Scholar
• Amdur RL, Feldman HI, Gupta J, et al. Inflammation and progression of ckd: the cric study. Clin J Am Soc Nephrol. 2016;11(9):1546–1556.
   PubMed Web of Science ®Google Scholar
• Li L, Tang L, Yang X, et al. Gene regulatory effect of pyruvate kinase m2 is involved in renal inflammation in type 2 diabetic nephropathy. Exp Clin Endocrinol Diabetes. 2020;128(9):599–606.
   Web of Science ®Google Scholar
• Gordin D, Shah H, Shinjo T, et al. Characterization of glycolytic enzymes and pyruvate kinase m2 in type 1 and 2 diabetic nephropathy. Diabetes Care. 2019;42(7):1263–1273.
   Web of Science ®Google Scholar
• Liu H, Takagaki Y, Kumagai A, Kanasaki K, Koya D. The pkm2 activator tepp-46 suppresses kidney fibrosis via inhibition of the emt program and aberrant glycolysis associated with suppression of hif-1alpha accumulation. J Diabetes Investig. 2021;12(5):697–709.
   Web of Science ®Google Scholar
• Zhang Z, Deng X, Liu Y, Liu Y, Sun L, Chen F. Correction to: pkm2, function and expression and regulation. Cell Biosci. 2019;9:59.
   PubMed Web of Science ®Google Scholar
• Niewczas MA, Gohda T, Skupien J, et al. Circulating tnf receptors 1 and 2 predict esrd in type 2 diabetes. J Am Soc Nephrol. 2012;23(3):507–515.
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Tanuma N, Shibuya R, et al. Pyruvate kinase type m2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species. Int J Oncol. 2018;52(3):881–891.
   Web of Science ®Google Scholar
• Angiari S, Runtsch MC, Sutton CE, et al. Pharmacological activation of pyruvate kinase m2 inhibits cd4(+) t cell pathogenicity and suppresses autoimmunity. Cell Metab. 2020;31(2):391–405 e398.
   PubMed Web of Science ®Google Scholar
• Sweetwyne MT, Gruenwald A, Niranjan T, Nishinakamura R, Strobl LJ, Susztak K. Notch1 and notch2 in podocytes play differential roles during diabetic nephropathy development. Diabetes. 2015;64(12):4099–4111.
   Web of Science ®Google Scholar
• Aung MH, Kim MK, Olson DE, Thule PM, Pardue MT. Early visual deficits in streptozotocin-induced diabetic long evans rats. Invest Ophthalmol Vis Sci. 2013;54(2):1370–1377.
   Web of Science ®Google Scholar
• Rajala A, Wang Y, Brush RS, et al. Pyruvate kinase m2 regulates photoreceptor structure, function, and viability. Cell Death Dis. 2018;9(2):240.
   Web of Science ®Google Scholar
• Lambert V, Hansen S, Schoumacher M, et al. Pyruvate dehydrogenase kinase/lactate axis: a therapeutic target for neovascular age-related macular degeneration identified by metabolomics. J Mol Med (Berl). 2020;98(12):1737–1751.
   Web of Science ®Google Scholar
• Rajala A, Soni K, Rajala RVS. Metabolic and non-metabolic roles of pyruvate kinase m2 isoform in diabetic retinopathy. Sci Rep. 2020;10(1):7456.
   Web of Science ®Google Scholar
• Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O’Neal DN, Januszewski AS. Biomarkers in diabetic retinopathy. Rev Diabet Stud. 2015;12(1–2):159–195.
   PubMedGoogle Scholar
• Heng LZ, Comyn O, Peto T, et al. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med. 2013;30(6):640–650.
   PubMed Web of Science ®Google Scholar
• Scarl RT, Lawrence CM, Gordon HM, Nunemaker CS. Steap4: its emerging role in metabolism and homeostasis of cellular iron and copper. J Endocrinol. 2017;234(3):R123–R134.
   Web of Science ®Google Scholar
• Liu L, Xu H, Zhao H, Jiang C. Steap4 inhibits hif-1alpha/pkm2 signaling and reduces high glucose-induced apoptosis of retinal vascular endothelial cells. Diabetes Metab Syndr Obes. 2020;13:2573–2582.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Hsieh YJ, Cheng WC, et al. Jmjd5 regulates pkm2 nuclear translocation and reprograms hif-1alpha-mediated glucose metabolism. Proc Natl Acad Sci U S A. 2014;111(1):279–284.
   Web of Science ®Google Scholar